| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9855f853f24337072ce02f44383942c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ed2e3189a0649929f9e38c436a92846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b65624ee4f8c8878257c719b891719b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25acc94f0d9d8d7ed56e95f08ed95bd9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06V2201-03 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06V20-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F18-24147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F18-2115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B40-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-00 |
| filingDate |
2012-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f712d2994ff65041a4e807289b71e38f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8a2bf98d809a93f00d07e7e9ca1935a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5992d182c3f9b3b9181406a4feba1c9d |
| publicationDate |
2012-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012191370-A1 |
| titleOfInvention |
Method and system for determining whether a drug will be effective on a patient with a disease |
| abstract |
A process of determining whether a patient with a disease or disorder will be responsive to a drug, used to treat the disease or disorder, including obtaining a test spectrum produced by a mass spectrometer from a serum produced from the patient. The test spectrum may be processed to determine a relation to a group of class labeled spectra produced from respective serum from other patients having the or similar clinical stage same disease or disorder and known to have responded or not responded to the drug. Based on the relation of the test spectrum to the group of class labeled spectra, a determination may be made as to whether the patient will be responsive to the drug. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8467988-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015340216-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022084993-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10153146-B2 |
| priorityDate |
2006-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |